The<unk>  (AAM), Washington, D.C., is a trade<unk>  representing the manufacturers and distributors of generic prescription drugs, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the U.S. generic drug industry. As the primary lobby for makers of generic drugs, AAM's stated mission is to advocate for public policies that facilitate timely access to lower-cost, FDA-approved generic and biosimilar<unk>  by consumers and patients. Over the 10-year period 2008 through 2018, the use of generic drugs generated $2 trillion in U.S. healthcare savings. Prior to February 2017, AAM was the Generic Pharmaceutical<unk>  (GPhA).
Association for Accessible Medicines
Military medical ethics
Public security
Organ procurement organization
Association for Perioperative Practice
Task Force on Prescription Drugs
Community health trust
Outline of medicine